Benjamin Dibling

1.5k citations
8 papers · 1.3k · 1 hit paper · h-index 8

Impact in

    • NF-κB Signaling Pathways
    • Cancer, Hypoxia, and Metabolism
  • Immunology top 10%
    • Immune Response and Inflammation

Papers in

    • Cell death mechanisms and regulation 5
    • Epigenetics and DNA Methylation 2
    • Cancer-related Molecular Pathways 3
    • Cytokine Signaling Pathways and Interactions 1

Benjamin Dibling

8 papers receiving 1.3k citations

Benjamin Dibling's Hit Papers

Inhibition of JNK activation through NF-κB target genes 2001 · 622 citations
6220+8+16Years since publication200400600

Peers

Benjamin Dibling
Comparison fields: 5 of 94
  • Cancer Research 489
  • Immunology 276
  • Molecular Biology 841
  • Oncology 279
  • Epidemiology 277
Replace Nathan Majewski with:
Nathan Majewski United States
Andrée Yeramian Spain
Xueli Pang China
Mi Ran Kang South Korea
Alan Zwart United States
Kathrin Gottlob United States
Qiang Du United States
Kyung Song United States
Francesco Pacifico Italy
D. Dubik Canada
Benjamin Dibling relative to Nathan Majewski United States Nathan Majewski's profile →
Citations per field
00.5×1.7×
Nathan Majewski · 1×
Citations per year

Countries citing papers authored by Benjamin Dibling

Since Specialization
Citations

This map shows the geographic impact of Benjamin Dibling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Dibling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Dibling more than expected).

Fields of papers citing papers by Benjamin Dibling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Dibling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Dibling. The network helps show where Benjamin Dibling may publish in the future.

Co-authors

The 20 scholars most cited alongside Benjamin Dibling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Dibling Line = papers co-authored together Benjamin Dibling links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Inhibition of JNK activation through NF-κB target genes
Hit paper breakdown →
2001622
2 2007311
3 2002129
4 200474
5 200373
6 200436
7 200227
8 200722

About Benjamin Dibling

Benjamin Dibling is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Surgery, having authored 8 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Cancer-related Molecular Pathways (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Epigenetics and DNA Methylation (2 papers), NF-κB Signaling Pathways (2 papers), Pancreatic function and diabetes (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (489 citations), Immunology (276 citations), Molecular Biology (841 citations), Oncology (279 citations) and Epidemiology (277 citations). Benjamin Dibling has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Anning Lin, Michael Karin, Nicole H. Purcell, Yuzuru Minemoto, Guilin Tang, Zhiwei Li, Kay F. Macleod, Benjamin T. Spike, Kristin Tracy and Paul T. Schumacker. Their work appears in journals such as The EMBO Journal, Current Opinion in Genetics & Development, Journal of Biological Chemistry, Nature and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact